🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
This is a phase I single center dose escalation study with an extension at ...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-11-08
Trial ID
NCT01634217
Treatments Being Tested
To evaluate if hyper-fractionated TBI or TMLI followed by Treg/Tcon adoptiv...
Status
Unknown
Location
University of Perugia
Start Date
2014-02
Trial ID
NCT03977103
Treatments Being Tested
The immune system has offensive and defensive capacities. In bone marrow tr...
Status
Terminated
Location
Katholieke Universiteit Leuven
Start Date
2013-07
Trial ID
NCT01903473
Treatments Being Tested
Prognosis of patients with graft failure is dismal, and re-transplantation ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2021-12-01
Trial ID
NCT05126186
Treatments Being Tested
The purpose of this study is to investigate the safety and therapeutic effe...
Status
Unknown
Location
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Start Date
2016-10
Trial ID
NCT02932826
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of QEL...
Status
Active Not Recruiting
Location
H. Saint Luc
Start Date
2022-01-21
Trial ID
NCT05234190
Treatments Being Tested
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623